Anonymous
Guest
Anonymous
Guest
Maybe Bausch will break 10% market share?
Hercules in development! All going down.
"Hercules" A product that does not fit on to any existing line Valeant has and needs an entirely new platform and before the layoffs and while we had everyone on site could not even make it to clinical trials is somehow going to "go down"! You are delirious and need help!
Or maybe the best of the best can pull it out of their bums! Good Luck!
What % of market share is Ultra right now ?
For Planned replacement. 5‰ ? 25 % ?LOLz
Come on guys. I want numbers. Is this lens going to be a game changer for Bausch and Lomb ? What are the plans to enter new markets or increase market share ? Will there be a big push in 2017 ? Is manufacturing ready to step up ?
I may only have half the time at Bausch but see it the same way. We've have great products but mostly B-list execs and marketing. Nike contact lenses anyone? Event if we got away from Valeant, I doubt we will ever get the leadership to raise us above an also ran company.Been with B&L 25 years and this is how I see it....B&L makes the best lenses period. Whether it's dailys or frequent replacement lenses or even RGP's (yes we still make them) they just have the best quality, acuity, comfort and fit.
Customers (yes, lens wearers are customers NOT patients) are introduced to lenses by their eye-care professional (or Bob in Walmart) and really don't get to choose lenses until they have been 5/6 yrs wearing them.
B&L Marketing and Sales Depts have always lagged behind the competition, we have a better quality product at similar price but failed to get that across to professionals/customers. Lens R&D, Manufacturing, Engineering, Distribution etc have never been perfect but they have batted above average to innovate and lower cost, just to be let down by the marketeers and sales folks, who in turn have been let down by exec mgmt not investing the time and dollars into that area. Valeant is a piece of crap and it's really bad we ended up there,but that's a reflection on executive management level.